Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + IFN + Vinblastine in mRCC
NCT00520403Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2007
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in renal cell carcinoma (RCC), sponsored by Roche. Started Sep 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00520403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520403.